Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/1596
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKarnik, SR-
dc.contributor.authorTathed, PS-
dc.contributor.authorAntarkar, DS-
dc.contributor.authorGidse, CS-
dc.contributor.authorVaidya, RA-
dc.contributor.authorVaidya, ADB-
dc.date.accessioned2008-06-27T08:39:20Z-
dc.date.available2008-06-27T08:39:20Z-
dc.date.issued2008-04-
dc.identifier.issn0972-5938-
dc.identifier.urihttp://hdl.handle.net/123456789/1596-
dc.description330-334en_US
dc.description.abstractTraditional systems of medicine, such as Ayurveda and Chinese medicine in Asia have been provided novel concepts and modalities for healthcare. Critical bedside observations by astute physicians have been followed up by systematic trans-disciplinary research. Such clinical hits of novel biodynamic actions can lead to new drug candidates. In the study, this path was taken up to document antimalarial activity of Nyctanthes arbor-tristis Linn. (Parijat). Nyctanthes arbor-tristis Linn., a popular plant with fragrant flowers described in Ayurveda is being sporadically used for malaria by several Ayurvedic physicians. Patients with malaria were treated with the paste of five fresh leaves of Nyctanthes arbor-tristis Linn, Given orally three times in a day for 7-10 days. The relief of symptoms and signs of malaria and the features of Visham jwara were graded basally and daily. Of 120 patients, ninety two (76.7%) showed complete clinical and parasitic cure within 7 days. Other 20 patients, who then continued on the same treatment, were cured by 10 days. Those patients who did not respond clinically and by parasite clearance were treated with standard antimalarial therapy. Parasite clearance was gradual and showed a direct temporal relationship with the level of initial parasitemia. The paste was well tolerated and no severe side effects were reported. Nyctanthes arbor-tristis Linn, with the dose used showed significant clinical antimalarial activity and good tolerability. A standardized formulation has to be prepared for further studies with critical markers of disease severity as well as parasite clearance.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.relation.ispartofseriesInt. Cl.⁸ : A61K36/00, A61P29/00, A61P33/06en_US
dc.sourceIJTK Vol.7(2) [April 2008]en_US
dc.subjectAntimalarial activityen_US
dc.subjectAyurvedic drugsen_US
dc.subjectTraditional medicineen_US
dc.subjectNyctanthes arbor-tristis Linnen_US
dc.subjectVisham jwaraen_US
dc.subjectParijaten_US
dc.titleAntimalarial activity and clinical safety of traditionally used Nyctanthes arbor-tristis Linn.en_US
dc.typeArticleen_US
Appears in Collections:IJTK Vol.07(2) [April 2008]

Files in This Item:
File Description SizeFormat 
IJTK 7(2) 330-334.pdf177.78 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.